• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球癌症负担及相关风险因素 204 个国家和地区,1980-2021 年:GBD 2021 系统分析。

Global burden of cancer and associated risk factors in 204 countries and territories, 1980-2021: a systematic analysis for the GBD 2021.

机构信息

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Biomedical Materials Engineering Research Center, Hubei Key Laboratory of Polymer Materials, Ministry-of-Education Key Laboratory for the Green Preparation and Application of Functional Materials, School of Materials Science & Engineering, State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei University, Wuhan, China.

出版信息

J Hematol Oncol. 2024 Nov 29;17(1):119. doi: 10.1186/s13045-024-01640-8.

DOI:10.1186/s13045-024-01640-8
PMID:39614359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11607901/
Abstract

BACKGROUND

Cancer is the second most common cause of death globally. Therefore, it is imperative to investigate cancer incidence, mortality rates, and disability-adjusted life years (DALYs) to enhance preventive measures and healthcare resource allocation. This study aimed to assess cancer burden and associated risk factors in 204 countries and territories between 1980 and 2021.

METHODS

We selected data on cancer incidence and mortality rates and associated risk factors from the global burden of disease (GBD) study tool for 204 countries and territories from 1990 to 2021 and 1980 to 2021. We estimated the age-standardized incidence (ASIR) and age-standardized deaths (ASDR) of 34 cancer types categorized as level 3 causes based on the GBD hierarchy.

RESULTS

In 2021, cancer accounted for 14.57% (95% uncertainty interval: 13.65-15.28) of total deaths and 8.8% (7.99-9.67) of total DALYs in both sexes globally. ASIR and ASDR were 790.33 (694.43-893.01) and 116.49 (107.28-124.69), respectively. Additionally, females exhibited higher ASIR than males (923.44 versus 673.09), while males exhibited higher ASDR than females (145.69 versus 93.60). This indicates that policymakers should focus on the importance of gender equality in healthcare. Non-melanoma skin cancer exhibited the highest ASIR (74.10) in both sexes, while digestive cancers accounted for 39.29% of all cancer-related deaths, and Asia exhibited the heaviest cancer burden. In females, breast cancer exhibited the highest ASIR (46.40) and ASDR (14.55). In males, tracheal, bronchial, and lung cancer exhibited the highest ASIR (37.85) and ASDR (34.32), highlighting the urgent need for targeted tobacco control measures. Different cancers in various countries exhibit unique characteristics. Therefore, policymakers should formulate specific prevention and control strategies that reflect the cancer in their country. Tobacco was the primary level 2 risk factor for cancer DALYs in males. It accounted for 29.32% (25.32-33.14) of all cancer DALYs. Dietary risks, alcohol consumption, and air pollution accounted for 5.89% (2.01-10.73), 5.48% (4.83-6.11), and 4.30% (2.77-5.95) of male cancer DALYs, respectively. Therefore, policymakers should prioritize smoking regulation and other carcinogenic risks.

CONCLUSION

Cancer is a significant public health concern globally. Understanding the common etiologies of different cancers is essential for developing effective control strategies and targeted interventions.

摘要

背景

癌症是全球第二大常见死因。因此,调查癌症发病率、死亡率和伤残调整生命年(DALYs)对于加强预防措施和医疗资源配置至关重要。本研究旨在评估 1980 年至 2021 年间 204 个国家和地区的癌症负担和相关风险因素。

方法

我们从全球疾病负担(GBD)研究工具中选择了 1990 年至 2021 年和 1980 年至 2021 年间 204 个国家和地区的癌症发病率和死亡率数据以及相关风险因素。我们根据 GBD 层次结构,将 34 种癌症类型归类为 3 级病因,并估计了这些癌症的年龄标准化发病率(ASIR)和年龄标准化死亡率(ASDR)。

结果

2021 年,癌症占全球男女总死亡人数的 14.57%(95%不确定区间:13.65-15.28%)和总伤残调整生命年(DALYs)的 8.8%(7.99-9.67%)。ASIR 和 ASDR 分别为 790.33(694.43-893.01)和 116.49(107.28-124.69)。此外,女性的 ASIR 高于男性(923.44 比 673.09),而男性的 ASDR 高于女性(145.69 比 93.60)。这表明决策者应关注医疗保健中性别平等的重要性。非黑色素瘤皮肤癌在两性中的 ASIR 最高(74.10),而消化系统癌症占所有癌症相关死亡人数的 39.29%,亚洲的癌症负担最重。在女性中,乳腺癌的 ASIR(46.40)和 ASDR(14.55)最高。在男性中,气管、支气管和肺癌的 ASIR(37.85)和 ASDR(34.32)最高,突显出有必要针对烟草采取有针对性的控制措施。不同国家的不同癌症具有独特的特征。因此,决策者应制定具体的预防和控制策略,反映本国的癌症情况。在男性中,烟草是癌症 DALYs 的主要二级风险因素。它占所有癌症 DALYs 的 29.32%(25.32-33.14)。饮食风险、饮酒和空气污染分别占男性癌症 DALYs 的 5.89%(2.01-10.73%)、5.48%(4.83-6.11%)和 4.30%(2.77-5.95%)。因此,决策者应优先考虑吸烟管理和其他致癌风险。

结论

癌症是全球重大公共卫生问题。了解不同癌症的常见病因对于制定有效的控制策略和针对性干预措施至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ee/11607901/5c93e731b9c1/13045_2024_1640_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ee/11607901/7b8936d7b197/13045_2024_1640_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ee/11607901/010d0e28907c/13045_2024_1640_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ee/11607901/37f924516ba5/13045_2024_1640_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ee/11607901/e0fc9b1e131f/13045_2024_1640_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ee/11607901/5c93e731b9c1/13045_2024_1640_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ee/11607901/7b8936d7b197/13045_2024_1640_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ee/11607901/010d0e28907c/13045_2024_1640_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ee/11607901/37f924516ba5/13045_2024_1640_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ee/11607901/e0fc9b1e131f/13045_2024_1640_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ee/11607901/5c93e731b9c1/13045_2024_1640_Fig5_HTML.jpg

相似文献

1
Global burden of cancer and associated risk factors in 204 countries and territories, 1980-2021: a systematic analysis for the GBD 2021.全球癌症负担及相关风险因素 204 个国家和地区,1980-2021 年:GBD 2021 系统分析。
J Hematol Oncol. 2024 Nov 29;17(1):119. doi: 10.1186/s13045-024-01640-8.
2
Disparities in the global burden of tracheal, bronchus, and lung cancer from 1990 to 2019.1990年至2019年全球气管、支气管和肺癌负担的差异。
Chin Med J Pulm Crit Care Med. 2023 Mar 28;1(1):36-45. doi: 10.1016/j.pccm.2023.02.001. eCollection 2023 Mar.
3
Burden of Stomach Cancer Incidence, Mortality, Disability-Adjusted Life Years, and Risk Factors in 204 Countries, 1990-2019: An Examination of Global Burden of Disease 2019.204 个国家 1990-2019 年胃癌发病、死亡、伤残调整生命年及危险因素负担:2019 年全球疾病负担研究
J Gastrointest Cancer. 2024 Jun;55(2):787-799. doi: 10.1007/s12029-023-01005-3. Epub 2024 Jan 24.
4
Global, regional, and national cancer burdens of respiratory and digestive tracts in 1990-2044: A cross-sectional and age-period-cohort forecast study.1990-2044 年全球、区域和国家的呼吸道和消化道癌症负担:一项横断面和年龄-时期-队列预测研究。
Cancer Epidemiol. 2024 Aug;91:102583. doi: 10.1016/j.canep.2024.102583. Epub 2024 May 29.
5
Global and China burden of hormone-related cancers and risk factors, 1990-2021: results from the Global Burden of Disease Study 2021.1990 - 2021年全球及中国激素相关癌症负担与风险因素:全球疾病负担研究2021结果
BMC Public Health. 2025 Apr 28;25(1):1566. doi: 10.1186/s12889-025-22768-3.
6
Temporal trends of tracheal, bronchus, and lung cancer between 2010 and 2019, in Asian countries by geographical region and sociodemographic index, comparison with global data.2010 年至 2019 年亚洲国家按地理位置和社会人口指数划分的气管、支气管和肺癌的时间趋势,与全球数据比较。
Thorac Cancer. 2023 Jun;14(18):1668-1706. doi: 10.1111/1759-7714.14912. Epub 2023 May 1.
7
The Global Burden of Cancer 2013.《2013 年全球癌症负担》。
JAMA Oncol. 2015 Jul;1(4):505-27. doi: 10.1001/jamaoncol.2015.0735.
8
Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study.全球、区域和国家层面气管、支气管和肺癌的流行病学趋势:一项基于人群的研究。
J Hematol Oncol. 2020 Jul 20;13(1):98. doi: 10.1186/s13045-020-00915-0.
9
Global burden of thyroid cancer from 1990 to 2021: a systematic analysis from the Global Burden of Disease Study 2021.全球 1990 年至 2021 年甲状腺癌负担:2021 年全球疾病负担研究的系统分析。
J Hematol Oncol. 2024 Aug 27;17(1):74. doi: 10.1186/s13045-024-01593-y.
10
Trends in the incidence and DALYs of schizophrenia at the global, regional and national levels: results from the Global Burden of Disease Study 2017.全球、区域和国家层面精神分裂症发病率和伤残调整寿命年趋势:来自 2017 年全球疾病负担研究的结果。
Epidemiol Psychiatr Sci. 2020 Jan 13;29:e91. doi: 10.1017/S2045796019000891.

引用本文的文献

1
Global trends and inequalities in eye cancer burden: a comprehensive analysis based on the global burden of disease study.眼癌负担的全球趋势与不平等:基于全球疾病负担研究的综合分析
Front Med (Lausanne). 2025 Aug 14;12:1638733. doi: 10.3389/fmed.2025.1638733. eCollection 2025.
2
Whole-body MRI for opportunistic cancer detection in asymptomatic individuals: a systematic review and meta-analysis.全身磁共振成像用于无症状个体的机会性癌症检测:一项系统评价和荟萃分析。
Eur Radiol. 2025 Aug 30. doi: 10.1007/s00330-025-11976-5.
3
Can Salivary Biomarkers Serve as Diagnostic and Prognostic Tools for Early Detection in Patients with Colorectal Cancer? A Systematic Review.

本文引用的文献

1
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病负担研究 2021 年在 204 个国家和地区、811 个次国家级地点对 88 种风险因素的全球负担和证据强度:系统分析。
Lancet. 2024 May 18;403(10440):2162-2203. doi: 10.1016/S0140-6736(24)00933-4.
2
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
唾液生物标志物能否作为结直肠癌患者早期检测的诊断和预后工具?一项系统综述。
Curr Issues Mol Biol. 2025 Aug 12;47(8):647. doi: 10.3390/cimb47080647.
4
Severe and enduring prostate cancer burden attributable to smoking among old men amid global decline and socioeconomic disparities.在全球前列腺癌负担下降及存在社会经济差异的背景下,老年男性中归因于吸烟的严重且持久的前列腺癌负担情况。
Sci Rep. 2025 Aug 21;15(1):30728. doi: 10.1038/s41598-025-16160-9.
5
Dietary risk factors and cancer mortality burden from 1990 to 2021: a comparative study of China and global regions with varying sociodemographic development levels based on the Global Burden of Disease database.1990年至2021年饮食风险因素与癌症死亡负担:基于全球疾病负担数据库对中国与社会人口发展水平各异的全球区域的比较研究
Front Nutr. 2025 Aug 5;12:1628792. doi: 10.3389/fnut.2025.1628792. eCollection 2025.
6
Global, regional, and national burden of male breast cancer and predictions in the next 30 years: a systematic analysis of the global burden of disease study 2021.男性乳腺癌的全球、区域和国家负担以及未来30年的预测:对《2021年全球疾病负担研究》的系统分析
BMC Cancer. 2025 Aug 20;25(1):1344. doi: 10.1186/s12885-025-14681-0.
7
Stem cell transplantation cost in Iran.伊朗的干细胞移植费用。
BMC Health Serv Res. 2025 Aug 18;25(1):1094. doi: 10.1186/s12913-025-13251-1.
8
Population health management through human phenotype ontology with policy for ecosystem improvement.通过人类表型本体进行人群健康管理并制定生态系统改善政策。
Front Artif Intell. 2025 Aug 1;8:1496937. doi: 10.3389/frai.2025.1496937. eCollection 2025.
9
Prognostic analysis and development of a predictive model for pulmonary invasive mucinous adenocarcinoma.肺浸润性黏液腺癌的预后分析及预测模型的建立
J Thorac Dis. 2025 Jul 31;17(7):5146-5163. doi: 10.21037/jtd-2025-755. Epub 2025 Jul 15.
10
Global burden of chronic kidney disease due to hypertension (1990-2021): a systematic analysis of epidemiological trends, risk factors, and projections to 2036 from the GBD 2021 study.1990 - 2021年高血压所致慢性肾脏病的全球负担:全球疾病负担研究(GBD)2021的流行病学趋势、危险因素及至2036年预测的系统分析
BMC Nephrol. 2025 Aug 9;26(1):448. doi: 10.1186/s12882-025-04386-8.
3
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
4
Global, regional, and national burden of neck pain, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021.全球、区域和国家颈部疼痛负担,1990-2020 年,以及到 2050 年的预测:2021 年全球疾病负担研究的系统分析。
Lancet Rheumatol. 2024 Mar;6(3):e142-e155. doi: 10.1016/S2665-9913(23)00321-1.
5
Worldwide Prevalence and Disability From Mental Disorders Across Childhood and Adolescence: Evidence From the Global Burden of Disease Study.全球儿童和青少年期精神障碍的患病率和残疾负担:来自全球疾病负担研究的证据。
JAMA Psychiatry. 2024 Apr 1;81(4):347-356. doi: 10.1001/jamapsychiatry.2023.5051.
6
Global, regional, and national burden of other musculoskeletal disorders, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021.1990年至2020年全球、区域和国家其他肌肉骨骼疾病负担及到2050年的预测:全球疾病负担研究2021的系统分析
Lancet Rheumatol. 2023 Oct 23;5(11):e670-e682. doi: 10.1016/S2665-9913(23)00232-1. eCollection 2023 Nov.
7
Global, regional, and national burden of spinal cord injury, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家脊髓损伤负担,1990-2019 年:2019 年全球疾病负担研究的系统分析。
Lancet Neurol. 2023 Nov;22(11):1026-1047. doi: 10.1016/S1474-4422(23)00287-9.
8
Opportunities and Challenges of Kava in Lung Cancer Prevention.卡瓦在肺癌预防方面的机遇与挑战。
Int J Mol Sci. 2023 May 31;24(11):9539. doi: 10.3390/ijms24119539.
9
The Global Burden of Liver Disease.《全球肝脏疾病负担》
Clin Gastroenterol Hepatol. 2023 Jul;21(8):1978-1991. doi: 10.1016/j.cgh.2023.04.015. Epub 2023 Apr 28.
10
Stark differences in cancer epidemiological data between GLOBOCAN and GBD: Emphasis on oral cancer and wider implications.全球癌症发病率、死亡率及患病率数据库(GLOBOCAN)与全球疾病负担研究(GBD)之间癌症流行病学数据的显著差异:以口腔癌为例及更广泛的影响
EClinicalMedicine. 2022 Oct 6;54:101673. doi: 10.1016/j.eclinm.2022.101673. eCollection 2022 Dec.